Type 2 diabetes mellitus is associated with multiple cardiometabolic risk factors - PubMed (original) (raw)
Review
Type 2 diabetes mellitus is associated with multiple cardiometabolic risk factors
John E Gerich. Clin Cornerstone. 2007.
Abstract
The risk for cardiovascular disease (CVD) is multifactorial and includes such risk factors as diabetes, hypertension, smoking, and dyslipidemia. Thus, targeting the hyperglycemia in type 2 diabetes mellitus (DM) alone will not eliminate all of the excess cardiovascular risk; rather aggressive treatment is needed for all of the modifiable cardiometabolic risk factors. Therapeutic lifestyle change is considered primary therapy for hyperglycemia in type 2 DM. Currently, however, the focus in treatment is on preventing CVD rather than controlling glucose, lipid, or blood pressure (BP) levels. The American Diabetes Association guidelines identify low-density lipoprotein cholesterol as the first priority of lipid lowering, with optimal level set at <100 mg/dL (2.6 mmol/L). To reach the target BP level of <130/85 mm Hg, >65% of patients with DM and hypertension will require 2 or more different antihypertensive drugs. Strategies that combine thiazolidinediones and statins may have complementary effects on cardiovascular risk-factor profiles in type 2 DM, in addition to controlling glycemia. Despite the range of treatment options available, therapeutic agents that target new steps in the progression of CVD are needed, as patients with type 2 DM remain at increased risk and many do not achieve therapeutic targets with the drugs available.
Similar articles
- Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.
Ferdinand KC. Ferdinand KC. J Cardiometab Syndr. 2006 Spring;1(2):133-40. doi: 10.1111/j.1559-4564.2006.05487.x. J Cardiometab Syndr. 2006. PMID: 17679832 Review. - Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
Hausenloy DJ, Yellon DM. Hausenloy DJ, et al. Heart. 2008 Jun;94(6):706-14. doi: 10.1136/hrt.2007.125401. Heart. 2008. PMID: 18480348 Review. - Statins and diabetes.
Carmena R, Betteridge DJ. Carmena R, et al. Semin Vasc Med. 2004 Nov;4(4):321-32. doi: 10.1055/s-2004-869589. Semin Vasc Med. 2004. PMID: 15861314 Review. - Management of co-existing diabetes mellitus and dyslipidemia: defining the role of thiazolidinediones.
Florkowski CM. Florkowski CM. Am J Cardiovasc Drugs. 2002;2(1):15-21. doi: 10.2165/00129784-200202010-00003. Am J Cardiovasc Drugs. 2002. PMID: 14727995 Review. - Cardiovascular disease and modifiable cardiometabolic risk factors.
Cannon CP. Cannon CP. Clin Cornerstone. 2008;9(2):24-38; discussion 39-41. doi: 10.1016/s1098-3597(09)62037-8. Clin Cornerstone. 2008. PMID: 19410160
Cited by
- Influence of diabetes and obesity on ten-year outcomes after coronary artery bypass grafting in the arterial revascularisation trial.
Stefil M, Gaudino M, Benedetto U, Gerry S, Gray A, Lees B, Podesser B, Krzych L, Sajja LR, Taggart D, Flather M; ART Investigators. Stefil M, et al. Clin Res Cardiol. 2024 Nov;113(11):1515-1522. doi: 10.1007/s00392-023-02284-3. Epub 2023 Sep 23. Clin Res Cardiol. 2024. PMID: 37741811 Clinical Trial. - Patterns of change in obesity indices and other cardiometabolic risk factors before the diagnosis of type 2 diabetes: two decades follow-up of the Tehran lipid and glucose study.
Koohi F, Ahmadi N, Azizi F, Khalili D, Valizadeh M. Koohi F, et al. J Transl Med. 2022 Nov 8;20(1):518. doi: 10.1186/s12967-022-03718-8. J Transl Med. 2022. PMID: 36348481 Free PMC article. - Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic.
Ruissen MM, Regeer H, Landstra CP, Schroijen M, Jazet I, Nijhoff MF, Pijl H, Ballieux BEPB, Dekkers O, Huisman SD, de Koning EJP. Ruissen MM, et al. BMJ Open Diabetes Res Care. 2021 Jan;9(1):e002035. doi: 10.1136/bmjdrc-2020-002035. BMJ Open Diabetes Res Care. 2021. PMID: 33431602 Free PMC article. - Calpain Inhibition Restores Autophagy and Prevents Mitochondrial Fragmentation in a Human iPSC Model of Diabetic Endotheliopathy.
Ong SB, Lee WH, Shao NY, Ismail NI, Katwadi K, Lim MM, Kwek XY, Michel NA, Li J, Newson J, Tahmasebi S, Rehman J, Kodo K, Jang HR, Ong SG. Ong SB, et al. Stem Cell Reports. 2019 Mar 5;12(3):597-610. doi: 10.1016/j.stemcr.2019.01.017. Epub 2019 Feb 21. Stem Cell Reports. 2019. PMID: 30799273 Free PMC article. - Diabetes-related foot disorders among adult Ghanaians.
Sarfo-Kantanka O, Kyei I, Mbanya JC, Owusu-Ansah M. Sarfo-Kantanka O, et al. Diabet Foot Ankle. 2018 Sep 5;9(1):1511678. doi: 10.1080/2000625X.2018.1511678. eCollection 2018. Diabet Foot Ankle. 2018. PMID: 30202507 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical